U.S. markets open in 4 hours 25 minutes
  • S&P Futures

    4,137.50
    +19.50 (+0.47%)
     
  • Dow Futures

    33,747.00
    +123.00 (+0.37%)
     
  • Nasdaq Futures

    13,880.50
    +81.75 (+0.59%)
     
  • Russell 2000 Futures

    2,267.50
    +22.50 (+1.00%)
     
  • Crude Oil

    62.91
    -0.24 (-0.38%)
     
  • Gold

    1,747.10
    +10.80 (+0.62%)
     
  • Silver

    25.64
    +0.12 (+0.45%)
     
  • EUR/USD

    1.1988
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.6380
    0.0000 (0.00%)
     
  • Vix

    16.85
    +0.20 (+1.20%)
     
  • GBP/USD

    1.3786
    +0.0006 (+0.04%)
     
  • USD/JPY

    108.7600
    -0.1670 (-0.15%)
     
  • BTC-USD

    62,864.09
    -1,678.78 (-2.60%)
     
  • CMC Crypto 200

    1,372.69
    -3.08 (-0.22%)
     
  • FTSE 100

    6,973.46
    +33.88 (+0.49%)
     
  • Nikkei 225

    29,642.69
    +21.70 (+0.07%)
     

PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

SOUTH PLAINFIELD, N.J., Feb. 16, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:

Raymond James 42nd Annual Institutional Investors Conference
Tuesday, March 2nd at 7:30 a.m. ET

Cowen 41st Annual Health Care Conference
Thursday, March 4th at 10:30 a.m. ET

Barclays Global Healthcare Conference
Wednesday, March 10th at 9:10 a.m. ET

The presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

For More Information Please Contact:

Media & Investors:
Jane Baj
+1 (908) 912-9167
jbaj@ptcbio.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-virtual-investor-conferences-301227815.html

SOURCE PTC Therapeutics, Inc.